Gabrielle Sulzberger Eli Lilly & CO (LLY) insider trading activity

Gabrielle Sulzberger is Director of ELI LILLY & Co. Currently has a direct ownership of 2,516 shares of LLY, which is worth approximately $1.9 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 315 shares (Common Stock) at a price of $727.2 per share, resulting in proceeds of $229,068. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.52K

15.63% 3M change

22.31% 12M change

Total Value Held $1.9 Million

Gabrielle Sulzberger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	BUY Grant, award, or other acquisition	$229,068 $727.2 p/Share	315 Added 11.13%	2,516 Common Stock
Oct 21 2024	BUY Grant, award, or other acquisition	$9,967 $906.13 p/Share	11 Added 0.5%	2,201 Common Stock
Sep 16 2024	BUY Grant, award, or other acquisition	$10,158 $923.54 p/Share	11 Added 0.5%	2,190 Common Stock
Aug 19 2024	BUY Grant, award, or other acquisition	$10,139 $921.81 p/Share	11 Added 0.5%	2,176 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	$9,504 $950.46 p/Share	10 Added 0.46%	2,165 Common Stock
Jun 17 2024	BUY Grant, award, or other acquisition	$9,735 $885.01 p/Share	11 Added 0.51%	2,155 Common Stock
May 20 2024	BUY Grant, award, or other acquisition	$10,181 $783.18 p/Share	13 Added 0.6%	2,141 Common Stock
Apr 15 2024	BUY Grant, award, or other acquisition	$9,760 $750.77 p/Share	13 Added 0.61%	2,128 Common Stock
Mar 18 2024	BUY Grant, award, or other acquisition	$9,914 $762.66 p/Share	13 Added 0.61%	2,115 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	$9,823 $755.66 p/Share	13 Added 0.62%	2,098 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	$10,153 $634.57 p/Share	16 Added 0.76%	2,085 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	$5,217 $579.76 p/Share	9 Added 0.43%	2,069 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	$204,976 $597.6 p/Share	343 Added 14.29%	2,057 Common Stock
Oct 16 2023	BUY Grant, award, or other acquisition	$4,933 $616.64 p/Share	8 Added 0.46%	1,714 Common Stock
Sep 18 2023	BUY Grant, award, or other acquisition	$5,141 $571.28 p/Share	9 Added 0.52%	1,706 Common Stock
Aug 21 2023	BUY Grant, award, or other acquisition	$4,954 $550.5 p/Share	9 Added 0.53%	1,694 Common Stock
Jul 17 2023	BUY Grant, award, or other acquisition	$4,918 $447.14 p/Share	11 Added 0.65%	1,685 Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	$4,971 $451.95 p/Share	11 Added 0.65%	1,674 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$4,779 $434.51 p/Share	11 Added 0.66%	1,659 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	$4,840 $372.35 p/Share	13 Added 0.78%	1,648 Common Stock
Mar 20 2023	BUY Grant, award, or other acquisition	$5,004 $333.6 p/Share	15 Added 0.91%	1,635 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$4,912 $327.51 p/Share	15 Added 0.92%	1,614 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	$5,008 $357.74 p/Share	14 Added 0.87%	1,599 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	$10,017 $357.78 p/Share	28 Added 1.74%	1,585 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	$189,614 $361.17 p/Share	525 Added 25.25%	1,554 Common Stock

Also insider at

Mastercard Inc Financial Services

Director

BRX

Brixmor Property Group Inc. Real Estate

Director

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare

WRBY

Warby Parker Inc. Healthcare

Director